// App-Quantinova.ai

PO2306 : Determining the Optimal Dose of Cholecalciferol Supplementation for Children with CKD (C3 Trial): An Open-Label Multicentre Randomized Controlled Trial

Researchers

Presenter

  • Iyengar ArpanaA

Principal Investigators

  • Kamath Nivedita

  • V Hamsa

  • Uthup Susan

  • Sharma Jyoti

  • Singhal JyotiS

  • Ekambaram Sudha

  • Wan Mandy

  • Shroff Rukshana

Medical Centers

  • St John's Medical College Hospital Bangalore Karnataka India

  • Government medical College Hospital Trivandrum Kerala India

  • KEM HospitalPune Pune Maharashtra India

  • Mehta Hospitals Chennai Tamil Nadu India

  • Great Ormond Street Hospital for Children, London, England, United Kingdom

Locations

  • India

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • cholecalciferol

Outcome

  • N/A


Study Design

  • Randomized

  • Open Label

  • Multicenteric

  • Controlled

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A